Market News AIOpen the app

Levi & Korsinsky is looking into NeuroPace after it cut its revenue forecast for 2026.

ResultsRead the original at prnewswire.com
Bad for NPCE

NeuroPace cut its 2026 sales forecast to $91-$92 million from $99.5-$101.5 million after sales and customer problems. A law firm is checking possible disclosure violations, adding concern, though no violation is established.

NPCE · NeuroPace, Inc.

AI read · Bad for NPCE

The AI's read

The lower forecast means NeuroPace expects less sales income. Management linked the shortfall to sales-force changes, problems at large customer accounts, and leaving SEEG distribution. A law firm is also checking what shareholders were told, but the source does not say any violation has been found.

Get alerts for NPCE

Follow NeuroPace, Inc. (NPCE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NPCE
Free on the App Store and Google Play, or on the web.